Dechert Dominates LSPN 2025 Awards, Earning Top Accolades for Excellence in Life Sciences IP and Patent Licensing

Dechert LLP was named ‘Best Life Sciences IP Firm – Due Diligence for Life Sciences Transactions’ and awarded for ‘Excellence in Patent Licensing and Transactions’ at the LSPN 2025 Awards.

The LSPN Awards honor firms in the life sciences sector that have demonstrated exceptional client service, innovative product development and strong sustainable business growth over the past 12 months.

Dechert’s recognition as Best Life Sciences IP Firm – Due Diligence for Life Sciences Transactions is a testament to our rigorous and insightful IP due diligence, which has been instrumental in enabling successful life sciences M&A, financing and licensing deals. Our expertise in assessing patent portfolios, reviewing license agreements and evaluating the strength of lead programs has resulted in nearly US$3 billion in acquisitions and investor/partner funding in the past 12 months.

Our Excellence in Patent Licensing, and Transactions award highlights our ability to structure complex, high-stakes patent licensing deals and transactions. We have successfully negotiated significant licensing deals, joint ventures and strategic alliances, providing comprehensive IP support for major mergers and acquisitions.

In addition to these awards, Dechert received high commendation as the Life Sciences Prosecution Firm of the Year, acknowledging our exceptional work in building and managing patent portfolios. Nisha Patel Gupta received high commendation as the Rising Star of the Year, underscoring her remarkable contributions to the field.

We were also shortlisted in the following categories:

Firm Shortlists

• Case of the Year/Impact Case – Genzyme Corp. et al. v. Novartis Gene Therapy et al. (D. Del.) (PTAB)
• Life Sciences IP Firm of the Year
• Life Sciences IP Litigation Firm of the Year

Shortlisted Individuals

• Katherine A. Helm - Patent Litigator of the Year Award
• Andrea L.C. Reid - Patent Prosecutor of the Year Award

Dechert’s IP practice boasts over 50 partners, counsel, associates and patent agents across 10 offices globally, with more than 30 IP professionals registered to practice before the USPTO. Our team includes members with advanced degrees in life sciences disciplines, enhancing our collaboration with clients’ scientists and legal teams.

Winners were selected by a panel of judges and announced at the awards ceremony on May 6.

About Dechert

Dechert is a global law firm that advises asset managers, financial institutions and corporations on issues critical to managing their business and their capital – from high-stakes litigation to complex transactions and regulatory matters. We answer questions that seem unsolvable, develop deal structures that are new to the market and protect clients’ rights in extreme situations. Our nearly 1,000 lawyers across 16 offices globally focus on the financial services, private equity, private credit, real estate, life sciences and technology sectors.